Werkgroep Cardiologische centra Nederland

PARADIGM-2314 (Completed)

A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction
Medicine
LCZ 696 vs enalapril
Population
Heart failure
Phase
III
Starting year
2009
More information
ClinicalTrials.gov

Director of Study

dr. A. Mosterd (Cardioloog)
Amersfoort, Meander Medisch Centrum

PARADIGM-2314: News